Barclays Maintains Overweight on Braze, Raises Price Target to $31

Barclays analyst Raimo Lenschow has maintained an Overweight rating on Braze (NASDAQ: BRZE) and raised the price target from $29 to $31. This adjustment reflects positive expectations for the company's performance in the market.